tiprankstipranks
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF

RepliCel Life Sciences (REPCF) Stock Price & Analysis

22 Followers

REPCF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.03 - $0.19
Previous Close$0.04
Volume550.00
Average Volume (3M)10.26K
Market Cap
$2.65M
Enterprise Value$2.66M
Total Cash (Recent Filing)C$32.48K
Total Debt (Recent Filing)C$40.96K
Price to Earnings (P/E)8.8
Beta0.98
Apr 30, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding65,001,560
10 Day Avg. Volume3,946
30 Day Avg. Volume10,255
Standard Deviation0.22
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.54
Price to Sales (P/S)7.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio2.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

68.70%0.00%0.00%31.30%
68.70%
Insiders
0.00% Other Institutional Investors
31.30% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

REPCF FAQ

What was RepliCel Life Sciences Inc’s price range in the past 12 months?
RepliCel Life Sciences Inc lowest stock price was $0.03 and its highest was $0.19 in the past 12 months.
    What is RepliCel Life Sciences Inc’s market cap?
    Currently, no data Available
    When is RepliCel Life Sciences Inc’s upcoming earnings report date?
    RepliCel Life Sciences Inc’s upcoming earnings report date is Apr 30, 2024 which is in 33 days.
      How were RepliCel Life Sciences Inc’s earnings last quarter?
      Currently, no data Available
      Is RepliCel Life Sciences Inc overvalued?
      According to Wall Street analysts RepliCel Life Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does RepliCel Life Sciences Inc pay dividends?
        RepliCel Life Sciences Inc does not currently pay dividends.
        What is RepliCel Life Sciences Inc’s EPS estimate?
        RepliCel Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does RepliCel Life Sciences Inc have?
        RepliCel Life Sciences Inc has 65,001,560 shares outstanding.
          What happened to RepliCel Life Sciences Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of RepliCel Life Sciences Inc?
          Currently, no hedge funds are holding shares in REPCF
          ---

          RepliCel Life Sciences Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -59.22%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -26.22%
          Trailing 12-Months

          Company Description

          RepliCel Life Sciences Inc

          RepliCel Life Sciences, Inc. operates as a regenerative medicine company. The company focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. Its products includes RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin, and pattern baldness. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Alnylam Pharma
          BioLife Solutions
          Aclaris Therapeutics
          Oragenics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis